Developing Novel Combination Therapies for Pancreatic Cancer

Grant

Date/time Interval

  • December 1, 2016 - November 30, 2021
  • Total Award Amount

  • 1348584.00
  • Direct Costs

  • 908137.00
  • Sponsor Award Id

  • R01CA208272